Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing a uniform reporting system for preventable adverse drug events

D D Cousins1

  • 1United States Pharmacopeial Convention, Inc., Rockville, Maryland 20852-1790, USA.

Clinical Therapeutics
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Problem reporting systems.

Journal of the American Veterinary Medical Association·1994
Same author

Experience with a national medication error reporting program.

American journal of hospital pharmacy·1994
See all related articles

The United States Pharmacopeia (USP) developed MedMARx, a national anonymous reporting system for medication errors. This system enables hospitals to analyze and prevent errors using shared experiences for continuous quality improvement.

Area of Science:

  • Health Informatics
  • Patient Safety
  • Pharmacovigilance

Background:

  • Medication errors pose significant risks in healthcare settings.
  • Existing reporting systems often lack comprehensive data for analysis.
  • The United States Pharmacopeia (USP) has extensive experience in medication error reporting.

Purpose of the Study:

  • To introduce MedMARx, a novel nationwide, anonymous, Internet-accessible service for reporting medication errors.
  • To enable hospitals to benchmark medication errors and facilitate continuous quality improvement.
  • To leverage collective experiences for medication error risk analysis and prevention.

Main Methods:

  • Design and development of an anonymous, Internet-accessible reporting service by the USP Practitioners' Reporting Network.

Related Experiment Videos

  • Creation of data elements based on expert panel reviews and USP's prior experience.
  • Implementation of a system for hospitals to report and benchmark medication errors.

    • Main Results:

    • MedMARx provides an unprecedented ability for daily continuous quality improvement.
    • The system facilitates medication error risk analysis and prevention based on shared data.
    • The model's success suggests potential for broader healthcare applications.

    Conclusions:

    • MedMARx represents a significant advancement in medication error reporting and analysis.
    • The system empowers healthcare facilities with data-driven insights for enhanced patient safety.
    • The MedMARx model demonstrates potential for widespread adoption and impact across healthcare.